Epilepsy and EEG
Abstracts
P.003 Outcome of psychogenic nonepileptic seizures following diagnosis in the epilepsy monitoring unit
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S15
-
- Article
-
- You have access
- Export citation
Headache
Abstracts
P.004 Real-world effectiveness of intravenous eptinezumab in patients with chronic migraine and previous subcutaneous preventive migraine treatment
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S15
-
- Article
-
- You have access
- Export citation
P.005 Eptinezumab demonstrated efficacy regardless of prior preventive migraine treatment failure: post hoc DELIVER analyses
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S15
-
- Article
-
- You have access
- Export citation
P.006 Barriers and risk factors for emergency room visits vs smartphone app use for migraine in Canada and the United States
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S16
-
- Article
-
- You have access
- Export citation
P.007 Role of neuroimaging in headache management; are we following the guidelines?
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S16
-
- Article
-
- You have access
- Export citation
Movement Disorders
Abstracts
P.008 Spontaneous retropulsion in autopsy verified PSP
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S16
-
- Article
-
- You have access
- Export citation
MS/Neuroinflammatory Disease
Abstracts
P.009 Long-term comparative efficacy of inebilizumab from N-MOmentum participants versus azathioprine and immunosuppressants and placebo in NMOSD patients
-
- Published online by Cambridge University Press:
- 24 May 2024, pp. S16-S17
-
- Article
-
- You have access
- Export citation
P.010 Safety and efficacy of inebilizumab in AQP4+ NMOSD participants with history of immunosuppression treatment prior to N-MOmentum study
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S17
-
- Article
-
- You have access
- Export citation
P.011 Efficacy and safety of ravulizumab in adults with AQP4+ NMOSD: interim analysis from the ongoing phase 3 CHAMPION-NMOSD trial
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S17
-
- Article
-
- You have access
- Export citation
P.012 A global, long-term, prospective, observational registry of patients with AQP4+ NMOSD treated with complement component 5 inhibitor therapies eculizumab or ravulizumab
-
- Published online by Cambridge University Press:
- 24 May 2024, pp. S17-S18
-
- Article
-
- You have access
- Export citation
P.013 Accuracy of clinical assessments with virtual care in outpatient neurological setting
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S18
-
- Article
-
- You have access
- Export citation
P.014 Intravenous immunoglobulin use for central nervous system disorders in British Columbia: implementation of a provincial screening program
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S18
-
- Article
-
- You have access
- Export citation
Neuro-oncology
Abstracts
P.015 Spontaneous regression of acoustic schwannomas: a predictive model
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S18
-
- Article
-
- You have access
- Export citation
Neuroscience Education
Abstracts
P.016 Re-norming medical education: centering patient experience and diverse bodies in Lumbar Puncture (LP) instruction
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S19
-
- Article
-
- You have access
- Export citation
Neurovascular and Neurointerventional
Abstracts
P.017 Ischemic stroke in young adults: a comparison of outcomes, stroke risk factors and etiologies between males and females
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S19
-
- Article
-
- You have access
- Export citation
Other Adult Neurology
Abstracts
P.019 A shared decision-model toolkit for pregnancy related care in neurology
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S19
-
- Article
-
- You have access
- Export citation
P.020 Shifts in daytime functioning items on the insomnia severity scale with lemborexant after 6 months of treatment
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S20
-
- Article
-
- You have access
- Export citation
P.021 Nonclinical studies of abuse potential with dual orexin-receptor antagonists: concordance with real-world use
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S20
-
- Article
-
- You have access
- Export citation
Other Multidisciplinary
Abstracts
P.022 Gender disparity in canadian institutes of health research funding within neurology
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S20
-
- Article
-
- You have access
- Export citation
P.023 Review of imaging changes, cognitive decline, and dementia risk in cancer survivors after chemotherapy
-
- Published online by Cambridge University Press:
- 24 May 2024, p. S21
-
- Article
-
- You have access
- Export citation